NCT02107014View on ClinicalTrials.gov

Low Dose Naltrexone (LDN) Immune Monitoring

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Fibromyalgia
Interventions
DRUG

Low Dose Naltrexone

Naltrexone 4.5 mg p.o. nocte

Trial Locations (1)

94304

Stanford University School of Medicine, Palo Alto

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT02107014 - Low Dose Naltrexone (LDN) Immune Monitoring | Biotech Hunter | Biotech Hunter